Wockhardt, the long-standing pharmaceutical company, is in the midst of a transformation that could result in new ownership. The company's future is up in the air, with diverse potential investors reportedly showing interest. This move comes after a period of challenges for Wockhardt, which has encountered regulatory issues in recent years. Renown